Actual Medicinal Product (AMP) Rifater tablets (Imported)

Stability Information

(Some stability information inherited from generic)

Stability

Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

Rifater should be protected from excessive humidity and stored at 15–30°C.

Generic

Rifampicin + Isoniazid + Pyrazinamide

Formulation

Generic Rifater tablets